These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Type II fiber myolysis in a patient with hypocarnitinemia. Kimura S; Miyake S Brain Dev; 1989; 11(4):263-5. PubMed ID: 2774097 [TBL] [Abstract][Full Text] [Related]
3. Lipid storage myopathy associated with recurrent Reye syndrome-like attacks, but with a normal carnitine level. Matsuishi T; Yuge K; Aramaki S; Yoshino M; Yoshida I; Yamashita F Brain Dev; 1988; 10(2):125-9. PubMed ID: 3389475 [TBL] [Abstract][Full Text] [Related]
4. Systemic carnitine deficiency: benefit of oral carnitine supplements vs. persisting biochemical abnormalities. Duran M; de Klerk JB; Wadman SK; Scholte HR; Beekman RP; Jennekens FG Eur J Pediatr; 1984 Aug; 142(3):224-8. PubMed ID: 6468448 [TBL] [Abstract][Full Text] [Related]
5. Serum and urinary carnitine and organic acids in Reye syndrome and Reye-like syndrome. Sugimoto T; Nishida N; Woo M; Takeuchi T; Yasuhara A; Kobayashi Y; Sakane Y Brain Dev; 1986; 8(3):257-61. PubMed ID: 3766902 [TBL] [Abstract][Full Text] [Related]